European Journal of Pharmaceutical Sciences

Article	Citations
Design and development of microformulations for rapid release of small molecules and oligonucleotides	303
Some things old, new and borrowed: Delivery of dabrafenib and vemurafenib to melanoma cells via self-assembled nanomicelles based on an amphiphilic dendrimer	206
Novel thermosensitive small multilamellar lipid nanoparticles with promising release characteristics made by dual centrifugation	108
From extractables to exposure data: Sensitivity analysis of extrapolation algorithms with focus on USP 〈665〉	97
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment	93
Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storage	90
Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity	85
Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein	84
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos	76
On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state	70
Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects	69
Preparation, physicochemical characterization, ex vivo, and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery	61
Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations	61
Population pharmacokinetic analysis in children with different diseases treated with mycophenolate mofetil—Integrated analysis of clinical trials and real-world clinical data	61
Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial	56
Retraction notice to “Transdermal delivery of flurbiprofen from polyoxypropylene-polyoxyethylene block copolymer stabilized reduced graphene oxide to manage pain in spondylitis: In vitro and in vivo s	56
Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment	52
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	50
Miniaturized screening and performance prediction of tailored subcutaneous extended-release formulations for preclinical in vivo studies	49
Do we really target the receptors? Deposition and co-deposition of ICS-LABA fixed combination drugs	49
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators	49
Engineered mucoadhesive microparticles of formoterol/budesonide for pulmonary administration	49
Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms	48
Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors	48
Polymorphs of a 1:1 salt of sulfadiazine and piperazine–relative stability, dissolution studies, pharmacokinetics and anti-meningitis efficiency	47

In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop™	46
Enhancement of skin permeation of fluorescein isothiocyanate-dextran 4 kDa (FD4) and insulin by thermalporation	46
Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes	46
3D printed extended-release hydrochlorothiazide tablets	45
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	44
Pharmaceutical 3D-printing of nanoemulsified eucalypt extracts and their antimicrobial activity	44
Influence of P-glycoprotein on pulmonary disposition of the model substrate [11C]metoclopramide assessed by PET imaging in rats	44
Enhanced solubility and biopharmaceutical performance of atorvastatin and metformin via electrospun polyvinylpyrrolidone-hyaluronic acid composite nanoparticles	43
A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: An improved strategy against hearing loss	43
Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound?	41
Increasing the efficacy of abiraterone - from pharmacokinetics, through therapeutic drug monitoring to overcoming food effects with innovative pharmaceutical products	40
Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies	39
Editorial Board	38
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	38
Mechanistic insight into heat enhanced permeation of diclofenac and piroxicam in combination with chemical penetration enhancers across skin	37
Mucoadhesive meloxicam-loaded nanoemulsions: Development, characterization and nasal applicability studies	36
Age-related pharmacokinetics differences were observed between young and elderly populations of a novel PDE5 inhibitor, youkenafil, and its metabolite M459	36
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin	35
Microparticles and multi-unit systems for advanced drug delivery	35
Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions	34
Protein aggregation in the frozen state induced by dropping stress	34
A commentary on “Are all measures of liver Kpuu a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?”	33
Suicide nanoplasmids coding for ribosome-inactivating proteins	33
Development and evaluation of a novel biodegradable implants with excellent inflammatory response suppression effect by hot-melt extrusion	32
Editorial Board	32
Aerosol delivery of inhalation devices with different add-on connections to invasively ventilated COPD subjects: An in-vivo study	31
Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation	31
The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib	31
Influence of mesh nebulizer characteristics on aerosol delivery in non-human primates	31
Interaction of liposomes with bile salts investigated by asymmetric flow field-flow fractionation (AF4): A novel approach for stability assessment of oral drug carriers	30
Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes	30
Ultrasound-induced destruction of heparin-loaded microbubbles attenuates L-arginine-induced acute pancreatitis	29
Editorial Board	29
Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation	29
In silico design, synthesis and evaluation of a less toxic octinoxate alternative with suitable photoprotection properties	29
Assessing the contribution of UGT isoforms on raltegravir drug disposition through PBPK modeling	29
Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars	28
Safety, pharmacokinetics and exploratory exposure-response analysis of CX3002, a novel inhibitor of Xa, in Chinese healthy subjects	28
Editorial Board	28
Optimizing study design in LPS challenge studies for quantifying drug induced inhibition of TNFα response: Did we miss the prime time?	28
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	28
Editorial Board	28
Editorial Board	28
Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates	27
Novel cyclic C5-curcuminoids penetrating the blood-brain barrier: Design, synthesis and antiproliferative activity against astrocytoma and neuroblastoma cells	27
Evaluation of efficacy and safety after replacement of methyl hydrogen with deuterium at methyl formate of Clopidogrel	27
Open forum conference on the ICH M13A bioequivalence guideline	27
Editorial Board	27
Editorial Board	27
Preparation, evaluation, and pharmacokinetics in beagle dogs of a taste-masked flunixin meglumine orally disintegrating tablet prepared using hot-melt extrusion technology and D-optimal mixture design	26

Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents	26
Editorial Board	25
Development, optimization and ex-vivo evaluation of a transdermal formulation containing trazodone	25
Application of ionic liquid to enhance the nose-to-brain delivery of etodolac	25
Antiviral effects and mechanisms against EV71 of the novel 2-benzoxyl-phenylpyridine derivatives	25
Using extractables data from single-use components for extrapolation to process equipment-related leachables: The toolbox and justifications	24
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients	24
Editorial Board	24
Nanocomposite gels of poloxamine and Laponite for β-Lapachone release in anticancer therapy	23
Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer	23
Biopredictive capability assessment of two dissolution/permeation assays, µFLUX™ and PermeaLoop™, using supersaturating formulations of Posaconazole	23
Effect of protein binding on the pharmacokinetics of the six substrates in the Basel phenotyping cocktail in healthy subjects and patients with liver cirrhosis	22
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator	22
Ligand assisted CuAAC labelling and RP-HPLC analysis of zidovudine and Retrovir using propargyl-Fmoc probe	22
The role of progranulin in ischemic heart disease and its related risk factors	22
Norvancomycin for the treatment of central nervous system MRSA infections: A randomized controlled trial	22
Characterization of binding properties of ephedrine derivatives to human alpha-1-acid glycoprotein	22
Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation	22
Can histamine cause an enhancement of the cellular uptake and cytotoxicity of doxorubicin-loaded polylactide nanoparticles?	21
Development and validation of a porcine artificial colonic mucus model reflecting the properties of native colonic mucus in pigs	21
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	21
Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation	21
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19	21
Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide	21
Safety and efficacy of intratympanic histamine injection as an adjuvant to dexamethasone in a noise-induced murine model	21
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide	20
Assessing extent of brain penetration in vivo (Kp,uu,brain) in Göttingen minipig using a diverse set of reference drugs	20
Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches	20
Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment	20
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	20
Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study	20
Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities	20
Fibrous matrices facilitate pleurocidin killing of wound associated bacterial pathogens	19
Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method	19
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	19
Model informed drug development: HSK21542 PBPK model supporting dose decisions in specific populations	19
Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations	19
Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysi	19
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	19
The 2-aminoethyl diphenylborinate-based fluorescent method identifies quercetin and luteolin metabolites as substrates of Organic anion transporting polypeptides, OATP1B1 and OATP2B1	19
Toltrazuril alkalizer-modifying solid dispersions against Toxoplasma gondii: A pharmacotechnical strategy to improve the efficacy of the drug	19
Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drug	18
Exploring pharmaceutical powder behavior in commercial-scale bin blending: A DEM simulation study	18
The effect of process parameters on a continuous blending process monitored in-line by near-infrared spectroscopy	18
Comparison of ionizable lipids for lipid nanoparticle mediated DNA delivery	18
Solubility of digitoxin in supercritical CO2: Experimental study and modeling	18
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation	18
On the processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: Sporanox® pellets	18
Synthetic membrane selection for in vitro release testing (IVRT): A case study of topical mometasone furoate semi-solid dosage forms	18
Cubic liquid crystals containing propolis flavonoids as in situ thermo-sensitive hydrogel depots for periodontitis treatment: Preparation, pharmacodynamics and therapeutic mechanisms	18
Investigation of real-life drug intake behaviour in older adults and geriatric patients in Northern Germany – A biopharmaceutical perspective	18
Optimization of continuous spin-freeze-drying: The role of spin-freezing on quality attributes and drying efficiency of a model peptide formulation	18
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	17
Exploration of in vitro drug release testing methods for saquinavir microenvironmental pH modifying buccal films	17
Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept	17
Interface-sensitized prodrug nanoaggregate as an effective in situ antitumor vaccine	17
Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction	17
Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs – A case with sertaconazole nitrate	17
Design, synthesis and biological evaluation of naphthalene-derived (arylalkyl)azoles containing heterocyclic linkers as new anticonvulsants: A comprehensive in silico, in vitro, and in vivo study	17
Antibody conjugated lipid nanoparticles as a targeted drug delivery system for hydrophobic pharmaceuticals	17
Evaluation of the pharmacokinetic effects of itraconazole on alflutinib (AST2818): an open-label, single-center, single-sequence, two-period randomized study in healthy volunteers	17
Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy	17
Systematic thermodynamic analysis of apremilast polymorphs via solubility measurement with modeling: Mechanism evaluation through molecular simulation	16
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue	16
1-MT grafted carboxymethyl chitosan and its nanoparticles: Preparation, characterization and evaluation	16
A novel sodium caseinate lipid-based auto-emulsifying delivery system to increase resveratrol intestinal permeation: Characterization and in vitro assessment	16
Evaluation of cellulose based films comprising tea tree oil against dermatophytes and yeasts	16
Development of novel montmorillonite-based sustained release system for oral bromopride delivery.	16
Mechanisms of drug solubilization by polar lipids in biorelevant media	16
HM-3-HSA exhibits potent anti-angiogenesis and antitumor activity in hepatocellular carcinoma	16
Opportunities of topical drug products in a changing dermatological landscape	16
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	16
Insight of Synergistic Effect between CPP and Cargo on the Facilitation Mechanisms of R7-PTX Translocation: Experiments and Molecular Simulations	16
Skin absorption of mixed halide anions from concentrated aqueous solutions	16
In situ evaluation of spatiotemporal distribution of doxorubicin from Drug-eluting Beads in a tissue mimicking phantom	16
In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach	16
Effect of surfactant on the in vitro dissolution and the oral bioavailability of a weakly basic drug from an amorphous solid dispersion	16
Potent antibacterial activity in surgical wounds with local administration of D-PLEX100	15
Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation	15
Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys	15

Re article “Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity”, published in European Journal of Pharmaceutical S	15
Corrigendum to <Investigation on the mechanism of mafenide in inhibiting pyroptosis and the release of inflammatory factors [European Journal of Pharmaceutical Science147 (2020) 105303]	15
Mechanism insight on drug skin delivery from polyurethane hydrogels: Roles of molecular mobility and intermolecular interaction	15
Ultrasound combined with microbubbles enhances the renoprotective effects of methylprednisolone in rats with adriamycin-induced nephropathy	15
Elucidating the uptake and trafficking of nanostructured lipid carriers as delivery systems for miRNA	15
A novel heterometallic ruthenium-silver complex as potential antitumor agent: Studies on its synthesis, in vitro assays and interactions with biomolecular targets	15
Development of long-acting rivastigmine drug-in-adhesive patch utilizing ion-pair strategy and characterization of controlled release mechanism	15
How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.	15
Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy	15
Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin	15
Physiologically based pharmacokinetic modeling to assess the drug-drug interactions of anaprazole with clarithromycin and amoxicillin in patients undergoing eradication therapy of H. pylori infection	15
Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms✰	15
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel	15
Symmetrical and un-symmetrical curcumin analogues as selective COX-1 and COX-2 inhibitor	15
Corrigendum to ‘A proposed pediatric biopharmaceutical classification system for medications for chronic diseases in children’ [European Journal of Pharmaceutical Sciences 152 (2020) 105437]	15
Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs	15
Machine learning methods for prediction of food effects on bioavailability: A comparison of support vector machines and artificial neural networks	14
Preparation and evaluation of inhalable S-allylmercapto-N-acetylcysteine and nintedanib co-loaded liposomes for pulmonary fibrosis	14
Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules	14
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	14
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	14
Is equilibrium slurry pH a good surrogate for solid surface pH during drug dissolution?	14
First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect	14
Are all measures of liver Kp a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?	14
Fate of inhaled aerosols under the influence of glottal motion in a realistic in silico human tracheobronchial tree model	14
Nanoparticles-based therapeutics for the management of bacterial infections: A special emphasis on FDA approved products and clinical trials	14
The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market	14
Preparation of nanoparticle and nanoemulsion formulations containing repaglinide and determination of pharmacokinetic parameters in rats	14
Bactericidal activities and action mechanism of the novel antimicrobial peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection	14
Physiologically based pharmacokinetic modeling to characterize enterohepatic recirculation and predict food effect on the pharmacokinetics of hyzetimibe	14
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	14
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects	14
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model	14
Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway	14
Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation	14
Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations	14
Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity	14
Explicating the molecular level drug-polymer interactions at the interface of supersaturated solution of the model drug: Albendazole	14
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	14
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells	13
Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice	13
Pyrrolidine SS13 induces oxidative stress and autophagy-mediated cell death in colorectal cancer cells	13
Investigation of the anti-inflammatory and analgesic activities of promising pyrazole derivative	13
Preparation and characterization of colon-targeted pH/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers	13
Prolonged activity of a recombinant manganese superoxide dismutase through a formulation of polymeric multi-layer nanoassemblies targeting cancer cells	13
Application of TPGS as an efflux inhibitor and a plasticizer in baicalein solid dispersion	13
Dual stimuli-responsive mesoporous silica nanoparticles for efficient loading and smart delivery of doxorubicin to cancer with RGD-integrin targeting	13
Exosomes derived from lung cancer cells: Isolation, characterization, and stability studies	13
CADD, AI and ML in drug discovery: A comprehensive review	13
Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems	13
Physiologically based pharmacokinetic/pharmacodynamic modeling to evaluate the absorption of midazolam rectal gel	13
Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients	13
Role of exosomes in bone and joint disease metabolism, diagnosis, and therapy	13
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice	13
Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma	13
Investigating the effect of graphene oxide in chitosan/alginate-based foams on the release and antifungal activity of clotrimazole in vitro	13
Recent advances and clinical translation of liposomal delivery systems in cancer therapy	13
Protective effects of andrographolide sodium bisulfate on UV-induced skin carcinogenesis in mice model	13
Quantifying crystallinity of amlodipine maleate in amorphous solid dispersions produced by fluidized bed granulation using PAT tools	12
Research on genetic variant characteristics in ADME genes based on whole-exome sequencing in the Han Chinese population	12
MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING	12
Editorial Board	12
A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery	12
Editorial Board	12
Pitfalls in evaluating permeability experiments with Caco-2/MDCK cell monolayers	12
Heparan sulfate proteoglycan affinity of adeno-associated virus vectors: Implications for retinal gene delivery	12
FT-NIR models for predicting film quality parameters in titanium dioxide-free tablet coatings	12
Novel amorphous solid dispersion based on natural deep eutectic solvent for enhancing delivery of anti-tumor RA-XII by oral administration in rats	12
Editorial Board	12
Protein corona formation on lipidic nanocapsules: Influence of the interfacial PEG repartition	12
Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis	12
Nanoparticle-enabled In Situ drug potency activation for enhanced tumor-specific therapy	12
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights	12
The role of PRMT1 in cellular regulation and disease: Insights into biochemical functions and emerging inhibitors for cancer therapy	12
CRISPR/Cas9 based knockout of lncRNA MALAT1 attenuates TGF-β1 induced Smad 2/3 mediated fibrosis during AKI-to-CKD transition	12
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization	12
In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix	12
Dinitrophenol-mediated modulation of an anti-PD-L1 VHH for Fc-dependent effector functions and prolonged serum half-life	12
J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice	12
Green Approach Towards Morphology-Controlled Synthesis of Zein-Functionalized TiO2 Nanoparticles for Cosmeceutical Application	12
Stability evaluation from hydrogen peroxide spiking studies	12
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum	11
Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with breast, colorectal or gastric cancer under fed condition: A multicentric, randomized, open-label, single-d	11
From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment	11
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients	11
Editorial Board	11
Editorial Board	11
Evaluation of the 18F-labeled analog of the therapeutic all-D-enantiomeric peptide RD2 for amyloid β imaging	11
Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection	11
In-situ formation of nanoparticles from drug-loaded 3D polymeric matrices	11
Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study	11
Application of bootstrap f to dissolution data from biorelevant media and evidence of the conservative nature of bootstrap f	11
Metabolic, genetic, and pharmacokinetic parameters for the prediction of olanzapine efficacy	11
Salvianolic acid B-loaded polydopamine-modified hollow mesoporous organic silica nanoparticles for treatment of breast cancer metastasis via suppressing cancer-associated fibroblasts	11
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	11